Additional genes with significant amplification of expression exploit copy number changes (Beroukhim et al. 2010; Zack et al. 2013), e.g., of Myc transcription factor in pancreatic cancer (Oketch et al. 2023), and diffuse large B-cell and high-grade lymphoma (Schieppati et al. 2020), and MYC and TERT copy number variations in lung cancer (Brik et al. 2023). This evidence concerns the gene MYC and lung cancer.